Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 180

1.

The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa.

Wearne N, Swanepoel CR, Duffield MS, Davidson BJ, Manning K, Tiffin N, Boulle A, Rayner BL, Naidu P, Okpechi IG.

BMC Nephrol. 2019 Feb 6;20(1):44. doi: 10.1186/s12882-019-1208-2.

2.

Neonatal and infant diagnostic HIV-PCR uptake and associations during three sequential policy periods in Cape Town, South Africa: a longitudinal analysis.

Kalk E, Kroon M, Boulle A, Osler M, Euvrard J, Stinson K, Timmerman V, Davies MA.

J Int AIDS Soc. 2018 Nov;21(11):e25212. doi: 10.1002/jia2.25212.

3.

Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.

Kendall EA, Azman AS, Maartens G, Boulle A, Wilkinson RJ, Dowdy DW, Rangaka MX.

AIDS. 2019 Mar 1;33(3):525-536. doi: 10.1097/QAD.0000000000002053.

PMID:
30325773
4.

Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts.

de Waal R, Cohen K, Boulle A, Fox MP, Maartens G, Igumbor EU, Davies MA.

PLoS One. 2018 Sep 5;13(9):e0203530. doi: 10.1371/journal.pone.0203530. eCollection 2018.

5.

Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug resistant tuberculosis: a retrospective cohort study.

Zhao Y, Fox T, Manning K, Stewart A, Tiffin N, Khomo N, Leslie J, Boulle A, Mudaly V, Kock Y, Meintjes G, Wasserman S.

Clin Infect Dis. 2018 Aug 24. doi: 10.1093/cid/ciy727. [Epub ahead of print]

PMID:
30165431
6.
7.

What Should we do When HIV-Positive Children Fail First-Line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.

Patten G, Schomaker M, Davies MA, Rabie H, van Zyl G, Technau K, Eley B, Boulle A, Van Dyke RB, Patel K, Sipambo N, Wood R, Tanser F, Giddy J, Cotton M, Nuttall J, Essack G, Karalius B, Seage G lll, Sawry S, Egger M, Fairlie L; for IeDEA Southern Africa.

Pediatr Infect Dis J. 2018 Jul 31. doi: 10.1097/INF.0000000000002156. [Epub ahead of print]

PMID:
30067598
8.
9.

Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia.

Brennan AT, Bor J, Davies MA, Wandeler G, Prozesky H, Fatti G, Wood R, Stinson K, Tanser F, Bärnighausen T, Boulle A, Sikazwe I, Zanolini A, Fox MP.

Am J Epidemiol. 2018 Sep 1;187(9):1990-2001. doi: 10.1093/aje/kwy093.

PMID:
29767681
10.

Self-enrolment antenatal health promotion data as an adjunct to maternal clinical information systems in the Western Cape Province of South Africa.

Heekes A, Tiffin N, Dane P, Mutemaringa T, Smith M, Zinyakatira N, Barron P, Seebregts C, Boulle A.

BMJ Glob Health. 2018 Apr 24;3(Suppl 2):e000565. doi: 10.1136/bmjgh-2017-000565. eCollection 2018. Review.

11.

Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan Africa.

Rice B, Boulle A, Baral S, Egger M, Mee P, Fearon E, Reniers G, Todd J, Schwarcz S, Weir S, Rutherford G, Hargreaves J.

JMIR Public Health Surveill. 2018 Apr 3;4(2):e36. doi: 10.2196/publichealth.9344.

12.

The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.

Osler M, Hilderbrand K, Goemaere E, Ford N, Smith M, Meintjes G, Kruger J, Govender NP, Boulle A.

Clin Infect Dis. 2018 Mar 4;66(suppl_2):S118-S125. doi: 10.1093/cid/cix1140.

13.

Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes.

Ballif M, Zürcher K, Reid SE, Boulle A, Fox MP, Prozesky HW, Chimbetete C, Zwahlen M, Egger M, Fenner L; International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA).

BMJ Open. 2018 Jan 11;8(1):e017405. doi: 10.1136/bmjopen-2017-017405.

14.

Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania.

Semvua SK, Orrell C, Mmbaga BT, Semvua HH, Bartlett JA, Boulle AA.

PLoS One. 2017 Dec 18;12(12):e0189460. doi: 10.1371/journal.pone.0189460. eCollection 2017.

15.

Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.

Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, Davies MA.

PLoS Med. 2017 Dec 12;14(12):e1002468. doi: 10.1371/journal.pmed.1002468. eCollection 2017 Dec.

16.

Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes.

Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):413-416. doi: 10.1097/QAI.0000000000001611.

17.

Pharmacovigilance: A public health priority for South Africa.

Mehta U, Kalk E, Boulle A, Nkambule P, Gouws J, Rees H, Cohen K.

S Afr Health Rev. 2017;2017:125-133. Epub 2017 Aug 23.

18.

Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.

Kaplan SR, Oosthuizen C, Stinson K, Little F, Euvrard J, Schomaker M, Osler M, Hilderbrand K, Boulle A, Meintjes G.

PLoS Med. 2017 Nov 7;14(11):e1002407. doi: 10.1371/journal.pmed.1002407. eCollection 2017 Nov.

19.

Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.

Cornell M, Johnson LF, Wood R, Tanser F, Fox MP, Prozesky H, Schomaker M, Egger M, Davies MA, Boulle A; International Epidemiology Databases to Evaluate AIDS-Southern Africa collaboration.

J Int AIDS Soc. 2017 Sep 25;20(1):21902. doi: 10.7448/IAS.20.1.21902.

20.

Trends in maternal and neonatal mortality in South Africa: a systematic review protocol.

Damian DJ, Njau B, Lisasi E, Msuya SE, Boulle A.

Syst Rev. 2017 Aug 17;6(1):165. doi: 10.1186/s13643-017-0560-1.

Supplemental Content

Loading ...
Support Center